BCX9930, a Potent, Selective, Oral Factor D Inhibitor, Demonstrates Proof-of-Concept As Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
Kulasekararaj, Austin, Malherbe, Jacques Le Roux, McDonald, Andrew, Cornpropst, Melanie, Collis, Phil, Davidson, Matthew, Chen, Xilin, Tower, Kristin, Gesty-Palmer, Diane, Sheridan, William P., Risitano, Antonio
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article